Presented for attendees of the 59th AASLD Annual Meeting. This is not an official function/event of the American Association for the Study of Liver Diseases.
In this uniquely formatted interactive symposium modeled on a prime time talk show, thought leaders will present and discuss the most relevant hepatitis B virus (HBV) management and care issues. In particular, the program will integrate the latest clinical data on the 5 issues that form the acronym PRIME—patients, resistance, individualized therapy, management, and efficacy.
| Event Date |
Details |
| Sunday, November 02, 2008 |
6:30 PM - 8:30 PM
Local Time
Registration and Dinner 6:30 PM - 7:00 PM
Symposium 7:00 PM - 8:30 PM
|
Agenda
6:30 PM - 7:00 PM
Registration and Dinner
7:00 PM - 7:05 PM
Welcome and Introduction
Program Chair: Nezam H. Afdhal, MD, FRCPI
7:05 PM - 7:30 PM
Case 1: HBV Patient Populations
Moderator: Nezam H. Afdhal, MD, FRCPI
Faculty: Heiner Wedemeyer, MD
7:30 PM - 7:55 PM
Case 2: Efficacy, Resistance, and Durability
Moderator: Nezam H. Afdhal, MD, FRCPI
Faculty: Stephen Locarnini, MD, PhD, FRC (Path)
7:55 PM - 8:20 PM
Case 3: Management of Suboptimal Response
Moderator: Nezam H. Afdhal, MD, FRCPI
Faculty: Ching-Lung Lai, MD
8:20 PM - 8:30 PM
Audience Questions and Answers and Conclusion
Moderator: Nezam H. Afdhal, MD, FRCPI
All Faculty